Unknown PHASE4 INTERVENTIONAL 2-arm NCT01228292

Comparison of Slow Efficiency Daily Dialysis (SLEDD) With Unfractionated Heparin Versus Citrasate in Critically Ill Patients.

Sponsor: University Hospital, Antwerp

Conditions Acute Kidney Injury Hemodialysis

Interventions Citrasate Unfractionated heparin

Updated 5 times since 2017 Last updated: Oct 25, 2010 Started: Jan 31, 2011 Primary completion: Jan 31, 2012 Completion: Jan 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01228292, this PHASE4 trial focuses on Acute Kidney Injury and Hemodialysis and remains ongoing. Sponsored by University Hospital, Antwerp, it has been updated 5 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Feb 2017 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE4

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Antwerp

Data source: University Hospital, Antwerp

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Edegem, Belgium